More than Calcium

Ancient DNA analysis suggests that calcium and vitamin D deficiencies were not the only reasons that may have driven Neolithic Iberian people to drink milk.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, BBUMMost adult mammals can’t digest milk, but humans have evolved lactase persistence—the continued activity of the lactose-digesting enzyme lactase—several times, independently and in different parts of the world, during the last 10,000 years. Evolutionary biologists have proposed several theories to explain the strong selection for lactase persistence among dairy-consuming populations, but to date, none have provided definitive reasoning for the evolution of such an unusual digestive ability.

Analyzing ancient DNA from the skeletal remains of eight late Neolithic Iberian people, scientists now present evidence to suggest that one such hypothesis—that lactase persistence was selected for among early northern Europeans to allow people to drink milk to avoid calcium and vitamin D deficiencies—could not alone explain the rapid rise in lactase persistence across the continent. Their work was published in Molecular Biology and Evolution today (January 22).

“It is likely that the advantage provided to lactase-persistent individuals was not constant throughout time and space,” University College London’s Pascale Gerbault, whose own work focuses on the spread of lactase persistence in Europe but was not involved in the work, told The Scientist in an e-mail. The new study “may provide some support for this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies